Impact of Interscalene Block Combined With General Anesthesia on Burst Suppression in Shoulder Surgery Patients

July 27, 2025 updated by: Tugba KOK, Bezmialem Vakif University

The Effect of Interscalene Brachial Plexus Block Combined With General Anesthesia on Burst Suppression Ratio in Patients Undergoing Shoulder Surgery

This prospective, randomized, double-blind clinical study aimed to investigate the effects of combining general anesthesia with an interscalene brachial plexus block (ISB) on burst suppression ratio (BSR) and electroencephalographic (EEG) activity in patients undergoing elective shoulder surgery. A total of 50 patients were allocated into two groups: those receiving general anesthesia with ISB (Group B) and those receiving general anesthesia alone (Group K). Intraoperative EEG recordings were obtained from frontal electrodes (Fp1, Fp2, F7, F8) using a SedLine® monitor. Power spectral analysis was conducted for delta, theta, alpha, and beta frequency bands, alongside assessment of Patient State Index (PSI) and BSR.

Study Overview

Detailed Description

This prospective, randomized, double-blind clinical trial was conducted to evaluate the neurophysiological effects of combining interscalene brachial plexus block (ISB) with general anesthesia in patients undergoing elective shoulder surgery. The primary objective was to investigate how ISB influences intraoperative burst suppression ratio (BSR) and EEG-derived brain activity, using quantitative parameters such as power spectral densities of frequency bands and Patient State Index (PSI).

A total of 50 ASA I-III patients scheduled for shoulder surgery were randomly assigned into two groups: Group B (general anesthesia + ISB) and Group K (general anesthesia only). Standardized general anesthesia was maintained with sevoflurane in both groups. EEG data were recorded continuously using a SedLine® monitor from frontal electrodes (Fp1, Fp2, F7, F8) during four perioperative phases. Spectral analysis was performed using Fast Fourier Transform (FFT) and Welch's method to quantify power in the delta (0.5-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), and beta (13-30 Hz) bands. BSR was calculated based on the duration of EEG suppression epochs, while PSI and SEF (Spectral Edge Frequency) were recorded continuously.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Fatih
      • Istanbul, Fatih, Turkey, 34093
        • Bezmialem Vakif University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients classified as ASA Physical Status I-III
  • Aged between 18 and 65 years
  • Scheduled for elective shoulder surgery under general anesthesia, with or without interscalene brachial plexus block

Exclusion Criteria:

  • Advanced renal failure
  • Advanced hepatic failure
  • Body mass index (BMI) > 40 kg/m²
  • History of central nervous system disorders
  • Diagnosed psychiatric illness
  • History of substance abuse
  • Known allergy to any of the drugs used in the study
  • Refusal to participate or to provide informed consent

Termination Criteria:

  • Severe hypotension (mean arterial pressure < 50 mmHg despite treatment)
  • Severe bradycardia (heart rate < 40 bpm requiring intervention)
  • Profound hypoxia (SpO₂ < 90% despite oxygen support)
  • Drug-related allergic reactions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Patients in Group B received an ultrasound-guided interscalene brachial plexus block (ISB)
A total of 20 mL of 0.125% bupivacaine was administered around the C5-C6 nerve roots under real-time ultrasound visualization. Fifteen minutes after the block, both sensory and motor block assessments were performed to confirm effectiveness. Following confirmation of a successful block, a standardized general anesthesia protocol was initiated using 1-2 mg/kg propofol, 1 mcg/kg fentanyl, and 0.6 mg/kg rocuronium, followed by endotracheal intubation. Anesthesia was maintained with sevoflurane (1.0-1.3 MAC), and depth of anesthesia was continuously monitored using the SedLine® EEG monitor.
The intervention consisted of an ultrasound-guided interscalene brachial plexus block (ISB) administered to patients in Group B prior to general anesthesia. The block was performed using a posterior in-plane approach with real-time ultrasound visualization. A total of 20 mL of 0.125% bupivacaine was injected around the C5-C6 nerve roots under sterile conditions by experienced anesthesiologists.
Active Comparator: Patients in Group K did not receive any regional anesthesia prior to general anesthesia induction.
After standard monitoring was established, including ECG, non-invasive blood pressure, SpO₂, and SedLine® EEG monitoring, a 5-minute baseline EEG recording (Phase 0) was obtained with the patient at rest, eyes closed, and in a noise-minimized environment. Subsequently, general anesthesia was induced using 1-2 mg/kg propofol, 1 mcg/kg fentanyl, and 0.6 mg/kg rocuronium, followed by endotracheal intubation. Anesthesia was maintained with sevoflurane at 1.0-1.3 MAC in a mixture of 50% oxygen and air. To ensure adequate intraoperative analgesia, a remifentanil infusion (0.05-0.2 μg/kg/min) was administered and titrated according to Surgical Pleth Index (SPI) values, aiming to maintain SPI between 20-50.
General anesthesia without regional block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Burst Suppression Ratio (BSR)
Time Frame: peroperative
Burst Suppression Ratio (BSR): The main quantitative indicator of deep cortical suppression, calculated as the percentage of time the EEG signal remained in a suppression state (defined as amplitude <±10 μV for ≥0.5 seconds) during surgery. BSR was recorded continuously and analyzed across four perioperative phases (Phase 0-3).
peroperative
Power Spectral Density (PSD) Analysis
Time Frame: peroperative
The average spectral power (μV²) of EEG signals was analyzed for four conventional frequency bands-delta (0.5-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), and beta (13-30 Hz)-using FFT-based spectral analysis. These values were calculated from frontal electrodes (Fp1, Fp2, F7, F8), and comparisons were made between Group B (ISB group) and Group K (control group) at each phase.
peroperative
Patient State Index (PSI)
Time Frame: peroperative
The Patient State Index (PSI), a proprietary quantitative measure ranging from 0 to 100, is derived from multichannel electroencephalogram (EEG) signals using the SedLine® brain function monitoring system. Higher PSI values indicate lighter levels of anesthesia or increased cortical activity, whereas lower values correspond to deeper anesthetic states. In this study, PSI values were utilized to monitor the level of consciousness and cortical stability during the intraoperative period. Particular emphasis was placed on PSI trends observed during Phase 1 (following the administration of the interscalene block but prior to the induction of general anesthesia), in order to investigate any pre-anesthetic central nervous system effects attributable to the regional block.
peroperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Arterial Pressure (MAP)
Time Frame: peroperative
Intraoperative mean arterial pressure (MAP) was continuously monitored and recorded at predefined intervals throughout the procedure. Particular attention was paid to measurements taken during anesthesia induction, surgical positioning in the beach chair position, and skin incision. These data were analyzed to evaluate hemodynamic stability and to investigate the potential sympatholytic effects of the interscalene brachial plexus block (ISB).
peroperative
Anesthetic and Analgesic Drug Consumption
Time Frame: peroperative
Total doses of intraoperative sevoflurane, remifentanil, and propofol were recorded for each patient. Volatile anesthetic consumption was quantified in minimum alveolar concentration-hours (MAC-h). The aim was to evaluate whether ISB reduced the requirement for hypnotic and opioid agents during surgery.
peroperative
Postoperative Pain Scores
Time Frame: During PACU stay (up to 2 hours)
Postoperative pain intensity was assessed using the Numerical Rating Scale (NRS), which ranges from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity. Pain scores were recorded during the post-anesthesia care unit (PACU) stay, specifically within the first two hours following surgery, to evaluate early postoperative analgesia.
During PACU stay (up to 2 hours)
Nursing Delirium Screening Scale (NUDESC)
Time Frame: During PACU stay (up to 2 hours)
The Nursing Delirium Screening Scale (NU-DESC) is a validated, nurse-administered tool used to detect signs of postoperative delirium. It assesses five domains: disorientation, inappropriate behavior, inappropriate communication, illusions/hallucinations, and psychomotor retardation. Each domain is scored from 0 to 2, resulting in a total score ranging from 0 to 10. A total score of ≥2 indicates a high probability of delirium. In this study, NU-DESC scores were recorded during the early postoperative period to identify any acute cognitive changes.
During PACU stay (up to 2 hours)
Heart Rate (HR)
Time Frame: peroperative
Heart rate (HR) was continuously monitored intraoperatively and recorded at specified time points, with focused analysis during key phases such as anesthesia induction, patient positioning (beach chair position), and surgical incision. Group comparisons were made to assess ISB-associated modulation of cardiac autonomic response.
peroperative
Oxygen Saturation (SpO₂)
Time Frame: peroperative
Peripheral oxygen saturation (SpO₂) was monitored continuously during surgery and recorded at predetermined intervals. Measurements during critical phases, including induction, positioning, and incision, were evaluated to ensure adequate oxygenation and assess any indirect effects of ISB on respiratory function.
peroperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Kazım Karaaslan, MD, Bezmialem Vakif University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 29, 2025

Primary Completion (Actual)

July 15, 2025

Study Completion (Actual)

July 20, 2025

Study Registration Dates

First Submitted

July 2, 2025

First Submitted That Met QC Criteria

July 15, 2025

First Posted (Actual)

July 23, 2025

Study Record Updates

Last Update Posted (Actual)

July 30, 2025

Last Update Submitted That Met QC Criteria

July 27, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Electroencephalogram

Clinical Trials on Ultrasound-guided interscalene brachial plexus block (ISB)

Subscribe